OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine
Hisaka Igarashi, Mamoru Shibata, Akichika Ozeki, et al.
Journal of Pain Research (2021) Vol. Volume 14, pp. 3555-3564
Open Access | Times Cited: 8
Hisaka Igarashi, Mamoru Shibata, Akichika Ozeki, et al.
Journal of Pain Research (2021) Vol. Volume 14, pp. 3555-3564
Open Access | Times Cited: 8
Showing 8 citing articles:
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
Simona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 247
Simona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 247
Evidence-based guidelines for the pharmacological treatment of migraine
Raffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia (2025) Vol. 45, Iss. 4
Closed Access
Raffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia (2025) Vol. 45, Iss. 4
Closed Access
Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
Simona Guerzoni, Carlo Baraldi, Flavia Lo Castro, et al.
Brain and Behavior (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 9
Simona Guerzoni, Carlo Baraldi, Flavia Lo Castro, et al.
Brain and Behavior (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 9
Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study
Keisuke Suzuki, Shiho Suzuki, Tomohiko Shiina, et al.
Journal of Neurology (2023) Vol. 270, Iss. 9, pp. 4377-4384
Closed Access | Times Cited: 5
Keisuke Suzuki, Shiho Suzuki, Tomohiko Shiina, et al.
Journal of Neurology (2023) Vol. 270, Iss. 9, pp. 4377-4384
Closed Access | Times Cited: 5
Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5
One-Time Use of Galcanezumab or Fremanezumab for Migraine Prevention
Masahito Katsuki, Kenta Kashiwagi, Shin Kawamura, et al.
Cureus (2023)
Open Access | Times Cited: 4
Masahito Katsuki, Kenta Kashiwagi, Shin Kawamura, et al.
Cureus (2023)
Open Access | Times Cited: 4
Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial
Mamoru Shibata, Atsuko Nihira, Yuka Tanji, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 2007-2019
Open Access | Times Cited: 2
Mamoru Shibata, Atsuko Nihira, Yuka Tanji, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 2007-2019
Open Access | Times Cited: 2
Headache Education by E-Learning Through Social Networking Services (Social Media)
Masahito Katsuki, Maiko Nanri, Yuki Miyakoshi, et al.
Journal of Healthcare Leadership (2023) Vol. Volume 15, pp. 285-296
Open Access
Masahito Katsuki, Maiko Nanri, Yuki Miyakoshi, et al.
Journal of Healthcare Leadership (2023) Vol. Volume 15, pp. 285-296
Open Access
